Liver Cancer
Copyright ©2007 Baishideng Publishing Group Inc.
World J Gastroenterol. Oct 21, 2007; 13(39): 5180-5187
Published online Oct 21, 2007. doi: 10.3748/wjg.v13.i39.5180
Table 1 Viral, clinical and histopathological profiles of patients with SVR who developed HCC
Age/sexHCV genotypePre-IFN treatment
Occurrence of HCC
Duration until HCC (yr)
ALT (IU/L)FibrosisSteatosisBMIFibrosisSteatosisBMI
Case 167/M1b138F3Grade 228.4F2Grade 127.45.4
Case 258/M2a39F1Grade 123.5F2Grade 022.59.5
Case 368/Mn.t.111F4Grade 224.2F2Grade 225.09.6
Case 453/M1b82F2Grade 119.6NTNT20.38.4
Case 558/M1b21F3Grade 123.5NTNT24.83.3
Case 665/F2a145F3Grade 125.6F2Grade 126.72.9
Case 754/M1b85F2Grade 226.1F2Grade 122.44.9
Table 2 Pre-IFN viral, clinical and histopathological profiles of all patients with SVR
Age (mean ± SD)Sex (M/F)ALT (IU) (mean ± SD)Genotype (1/2/NT)Hepatic fibrosis (F1/F2/F3/F4/NT)Hepatic steatosis (Grade 0/1/2/3/NT)
All (n = 266)46.3 ± 14.3184/82112 ± 99102/142/20103/99/28/8/28116/95/19/1/35
HCC (n = 7)60.4 ± 6.26/189 ± 474/2/11/2/3/1/00/4/3/0/0
No HCC (n = 259)44.8 ± 13.3178/81113 ± 10098/140/19102/97/25/7/28116/91/16/1/35